IP Library Granted Patent US 7,553,929
Granted Patent B2
US 7,553,929 · App. 10/148,457 · Granted Jun 30, 2009

Cell permeable peptides for inhibition of inflammatory reactions and methods of use

Assignee: Vanderbilt University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,553,929
App. No.
10/148,457
Granted
Jun 30, 2009
Kind
B2
Abstract

The present invention relates to the delivery of biologically active molecules, such as peptides, into the interior of cells by administering to the cells a complex comprising the molecule linked to an importation competent signal peptide. Such delivery can be utilized, for example, to treat and/or prevent inflammatory conditions, e.g., but not limited to, systemic inflammatory reactions such as endotoxic shock, localized inflammatory reactions such as inflammatory skin diseases and conditions, and inflammatory diseases such as autoimmune diseases.

Claims (3)

1. An isolated peptide comprising a cell membrane-permeable hydrophobic region of a signal peptide and a cyclized NF-kB nuclear localization sequence comprising the amino acid sequence Cys-Xaa-Xaa-Gln-Arg-Lys-Arg-Gln-Lys-Xaa-Xaa-Xaa-Cys (SEQ ID NO:14), wherein Xaa is any amino acid or is absent.

2. The isolated peptide of claim 1 , wherein the cyclized NF-kB nuclear localization sequence comprises the amino acid sequence Cys-Tyr-Val-Gln-Arg-Lys-Arg-Gln-Lys-Leu-Met-Pro-Cys (SEQ ID NO:15).

3. The isolated peptide of claim 1 , wherein the isolated peptide comprises the amino acid sequence set forth in SEQ ID NO: 12.

Assignments (1)
CONFIRMATORY LICENSE Recorded Oct 24, 2019
From: VANDERBILT UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 050816/0246 →
Continuity (5)
Continuation In Part 0945007100 · Nov 29, 1999
Continuation In Part 0917075400 · Oct 13, 1998
Continuation 0905278400 · Mar 31, 1998
Continuation 0825885200 · Jun 13, 1994
Related Publication 20040235746A1 · Nov 25, 2004